全文获取类型
收费全文 | 7191篇 |
免费 | 553篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 217篇 |
妇产科学 | 155篇 |
基础医学 | 1004篇 |
口腔科学 | 149篇 |
临床医学 | 725篇 |
内科学 | 1687篇 |
皮肤病学 | 162篇 |
神经病学 | 462篇 |
特种医学 | 181篇 |
外国民族医学 | 3篇 |
外科学 | 975篇 |
综合类 | 73篇 |
现状与发展 | 1篇 |
一般理论 | 8篇 |
预防医学 | 717篇 |
眼科学 | 192篇 |
药学 | 525篇 |
中国医学 | 31篇 |
肿瘤学 | 447篇 |
出版年
2023年 | 63篇 |
2022年 | 93篇 |
2021年 | 257篇 |
2020年 | 145篇 |
2019年 | 188篇 |
2018年 | 203篇 |
2017年 | 184篇 |
2016年 | 146篇 |
2015年 | 220篇 |
2014年 | 261篇 |
2013年 | 313篇 |
2012年 | 482篇 |
2011年 | 504篇 |
2010年 | 238篇 |
2009年 | 257篇 |
2008年 | 448篇 |
2007年 | 497篇 |
2006年 | 436篇 |
2005年 | 389篇 |
2004年 | 413篇 |
2003年 | 342篇 |
2002年 | 323篇 |
2001年 | 179篇 |
2000年 | 183篇 |
1999年 | 146篇 |
1998年 | 56篇 |
1997年 | 32篇 |
1996年 | 25篇 |
1995年 | 24篇 |
1994年 | 23篇 |
1993年 | 24篇 |
1992年 | 73篇 |
1991年 | 54篇 |
1990年 | 66篇 |
1989年 | 57篇 |
1988年 | 43篇 |
1987年 | 54篇 |
1986年 | 57篇 |
1985年 | 37篇 |
1984年 | 24篇 |
1983年 | 16篇 |
1982年 | 22篇 |
1981年 | 16篇 |
1979年 | 27篇 |
1978年 | 16篇 |
1976年 | 14篇 |
1975年 | 13篇 |
1974年 | 13篇 |
1973年 | 17篇 |
1972年 | 13篇 |
排序方式: 共有7795条查询结果,搜索用时 15 毫秒
101.
Michelle Y L Tang Patrick H Y Chung Hau Y Chan Paul K H Tam Kenneth KY Wong 《Journal of pediatric surgery》2019,54(2):255-257
Objective
Helicobacter pylori infection is common among Asians. However, evidence in the recent years has demonstrated a decrease in the prevalence of H. pylori infection among children and adults worldwide. Our aim was to update its prevalence in symptomatic children in our locality in the recent 12?years and compared to the results of our previous review published in 2005.Methods
A retrospective review was carried out between 2005 and 2017. All children who presented with dyspepsia or gastrointestinal bleeding and underwent oesophagogastroduodenoscopy with antral biopsy taken were included. Patient demographics, endoscopic, or histological diagnosis and the H. pylori status were recorded.Main Results
A total of 602 patients were included. There was a statistically significant decreasing trend of H. pylori infection rate between 2005 and 2017 (p?=?0.003). The overall infection rate from this study was 12.8%, compared to 25.6% from our previous review. Overall failure of eradication with first-line antibiotic therapy has increased to 29.3% from 10% in our previous review.Conclusion
There was a decrease in the prevalence of H. pylori infection among symptomatic children for the recent 12?years, comparing to our previous data from 2005. We hypothesize that the reduction in prevalence of H. pylori infection among adults and the decrease in the practice of sharing chopsticks during meals have led to a decrease in transmission of the bacteria among family members in Hong Kong. However, the failure of eradication with first line treatment was higher, possibly due to the increase in antibiotics usage and resistance.Level of Evidence
III 相似文献102.
Amélie Huynh Le Maux Bernadette Pignol Delphine Behr-Roussel Jean-Luc Blachon Pierre-Etienne Chabrier Sandrine Compagnie Philippe Picaut Jacques Bernabé Fran?ois Giuliano Pierre Denys 《Toxins》2015,7(12):5462-5471
Intradetrusor injections of Botulinum toxin A—currently onabotulinumtoxinA—is registered as a second-line treatment to treat neurogenic detrusor overactivity (NDO). The common clinical practice is 30 × 1 mL injections in the detrusor; however, protocols remain variable and standardization is warranted. The effect of reducing the number of injection sites of Dysport® abobotulinumtoxinA (aboBoNTA) was assessed in the spinal cord-injured rat (SCI). Nineteen days post-spinalization, female rats received intradetrusor injections of saline or aboBoNTA 22.5 U distributed among four or eight sites. Two days after injection, continuous cystometry was performed in conscious rats. Efficacy of aboBoNTA 22.5 U was assessed versus aggregated saline groups on clinically-relevant parameters: maximal pressure, bladder capacity, compliance, voiding efficiency, as well as amplitude, frequency, and volume threshold for nonvoiding contractions (NVC). AboBoNTA 22.5 U significantly decreased maximal pressure, without affecting voiding efficiency. Injected in four sites, aboBoNTA significantly increased bladder capacity and compliance while only the latter when in eight sites. AboBoNTA significantly reduced NVC frequency and amplitude. This preclinical investigation showed similar inhibiting effects of aboBoNTA despite the number of sites reduction. Further studies are warranted to optimize dosing schemes to improve the risk-benefit ratio of BoNTA-based treatment modalities for NDO and further idiopathic overactive bladder. 相似文献
103.
Frank K. Huynh Xiaoke Hu Zhihong Lin James D. Johnson Matthew D. Hirschey 《Journal of inherited metabolic disease》2018,41(1):59-72
Several inherited metabolic disorders are associated with an accumulation of reactive acyl-CoA metabolites that can non-enzymatically react with lysine residues to modify proteins. While the role of acetylation is well-studied, the pathophysiological relevance of more recently discovered acyl modifications, including those found in inherited metabolic disorders, warrants further investigation. We recently showed that sirtuin 4 (SIRT4) removes glutaryl, 3-hydroxy-3-methylglutaryl, 3-methylglutaryl, and 3-methylglutaconyl modifications from lysine residues. Thus, we used SIRT4 knockout mice, which can accumulate these novel post-translational modifications, as a model to investigate their physiological relevance. Since SIRT4 is localized to mitochondria and previous reports have shown SIRT4 influences metabolism, we thoroughly characterized glucose and lipid metabolism in male and female SIRT4KO mice across different genetic backgrounds. While only minor perturbations in overall lipid metabolism were observed, we found SIRT4KO mice consistently had elevated glucose- and leucine-stimulated insulin levels in vivo and developed accelerated age-induced insulin resistance. Importantly, elevated leucine-stimulated insulin levels in SIRT4KO mice were dependent upon genetic background since SIRT4KO mice on a C57BL/6NJ genetic background had elevated leucine-stimulated insulin levels but not SIRT4KO mice on the C57BL/6J background. Taken together, the data suggest that accumulation of acyl modifications on proteins in inherited metabolic disorders may contribute to the overall metabolic dysfunction seen in these patients. 相似文献
104.
105.
The performance of a diagnostic test is best evaluated against a reference test that is without error. For many diseases, this is not possible, and an imperfect reference test must be used. However, diagnostic accuracy estimates may be biased if inaccurately verified status is used as the truth. Statistical models have been developed to handle this situation by treating disease as a latent variable. In this paper, we conduct a systematized review of statistical methods using latent class models for estimating test accuracy and disease prevalence in the absence of complete verification. Published 2014. This article is a U.S. Government work and is in the public domain in the USA. 相似文献
106.
Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia 下载免费PDF全文
Caroline Algrin Jean‐Louis Golmard Mauricette Michallet Oumedaly Reman Anne Huynh Aurore Perrot Anne Sirvent Adriana Plesa Véronique Salaun Marie‐Christine Béné Dominique Bories Olivier Tournilhac Hélène Merle‐Béral Véronique Leblond Magali Le Garff‐Tavernier Nathalie Dhedin 《European journal of haematology》2017,98(4):363-370
107.
108.
Three‐dimensional speckle tracking echocardiography–derived left atrial deformation analysis in acromegaly (Results from the MAGYAR‐Path Study) 下载免费PDF全文
109.
Ha T. Huynh Jeffrey H. Grubb Carole Vogler William S. Sly 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(42):17022-17027
Enzyme replacement therapy has been used successfully in many lysosomal storage diseases. However, correction of brain storage has been limited by the inability of infused enzyme to cross the blood–brain barrier (BBB). We recently reported that PerT-GUS, a form of β-glucuronidase (GUS) chemically modified to eliminate its uptake and clearance by carbohydrate-dependent receptors, crossed the BBB and cleared neuronal storage in an immunotolerant model of murine mucopolysaccharidosis (MPS) type VII. In this respect, the chemically modified enzyme was superior to native β-glucuronidase. Chemically modified enzyme was also delivered more effectively to heart, kidney, and muscle. However, liver and spleen, which express high levels of carbohydrate receptors, received nearly fourfold lower levels of PerT-GUS compared with native GUS. A recent report on PerT-treated sulfamidase in murine MPS IIIA confirmed enhanced delivery to other tissues but failed to observe clearance of storage in neurons. To confirm and extend our original observations, we compared the efficacy of 12 weekly i.v. infusions of PerT-GUS versus native GUS on (i) delivery of enzyme to brain; (ii) improvement in histopathology; and (iii) correction of secondary elevations of other lysosomal enzymes. Such correction is a recognized biomarker for correction of neuronal storage. PerT-GUS was superior to native GUS in all three categories. These results provide additional evidence that long-circulating enzyme, chemically modified to escape carbohydrate-mediated clearance, may offer advantages in treating MPS VII. The relevance of this approach to treat other lysosomal storage diseases that affect brain awaits confirmation. 相似文献
110.
Kwok-Chiu Chang Wing-Wai Yew Cheuk-Ming Tam Chi-Chiu Leung 《Antimicrobial agents and chemotherapy》2013,57(9):4097-4104
It is often necessary to include WHO group 5 drugs in the treatment of extensively drug-resistant tuberculosis (XDR-TB) and fluoroquinolone-resistant multidrug-resistant tuberculosis (MDR-TB). As clinical evidence about the use of group 5 drugs is scarce, we conducted a systematic review using published individual patient data. We searched PubMed and OvidSP through 7 April 2013 for publications in English to assemble a cohort with fluoroquinolone-resistant MDR-TB treated with group 5 drugs. Favorable outcome was defined as sputum culture conversion, cure, or treatment completion in the absence of death, default, treatment failure, or relapse. A cohort of 194 patients was assembled from 20 articles involving 12 geographical regions. In descending order of frequency, linezolid was used in treatment of 162 (84%) patients, macrolides in 84 (43%), clofazimine in 65 (34%), amoxicillin with clavulanate in 56 (29%), thioridazine in 18 (9%), carbapenem in 16 (8%), and high-dose isoniazid in 16 (8%). Cohort analysis with robust Poisson regression models and random-effects meta-analysis similarly suggested that linezolid use significantly increased the probability (95% confidence interval) of favorable outcome by 57% (10% to 124%) and 55% (10% to 121%), respectively. Defining significant associations by risk ratios ≥ 1.2 or ≤ 0.9, neither cohort analysis nor meta-analysis demonstrated any significant add-on benefit from the use of other group 5 drugs with respect to outcome for patients treated with linezolid, although selection bias might have led to underestimation of their effects. Our findings substantiated the use of linezolid in the treatment of XDR-TB or fluoroquinolone-resistant MDR-TB and call for further studies to evaluate the roles of other group 5 drugs. 相似文献